Cell Surgical Network Safety Data Paper

The Cell Surgical Network is proud to have published one of the largest peer reviewed safety data papers on the use of autologous stromal vascular fraction (SVF) to date.

Click here to download the Safety Data Paper.

A Prospective Safety Study of Autologous Adipose-Derived Stromal Vascular Fraction Using a Specialized Surgical Processing System

All outcome test data were collected in an online database over a 5-year period. Our study shows a very low number of reported adverse events and a reduction in pain ratings after 6 months or more across a variety of musculoskeletal diseases and improvements in a variety of other degenerative conditions. Our system for producing adipose-derived SVF therapy for our patients was safe and benefits could be measured for a long time after SVF deployment.

San Francisco Stem Cell Treatment Center

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

Thank you for your interest in the San Francisco Stem Cell Treatment Center. You have been added to our list.